Serum Sickness in Patients Receiving Equine Rabies Immunoglobulin
Journal Title: Journal of Communicable Diseases - Year 2018, Vol 50, Issue 2
Abstract
Background: Equine Rabies Immunoglobulin (ERIG) is being used for treatment of category-III animal bite cases. ERIG is economical as compared to Human Rabies Immunoglobulin (HRIG) and hence more affordable to patients in developing countries, like India. Despite high degree of purification, there are reported cases of serum sickness like reactions, anaphylaxis, and other allergic reactions following ERIG administration. Serum sickness is a type III or immune-complex-mediated hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum. Because of fear of side effects (including serumsickness-like reaction) following ERIG, the use of ERIG is minimal among doctors. Objective: (1) To assess the incidence of serum sickness following the administration of ERIG. (2) To see the clinical features of serum sickness. Methods: This is a hospital-based cross-sectional study carried out in the ARV OPD of SCB Medical College, Cuttack, Odisha, India. All patients who received ERIG between September 2016 and December 2016 were included in the study. Side effects were monitored during the subsequent follow-up visits. Results: Out of 1548 category-III animal bite cases who received ERIG, 3.1% developed serum-sickness-like reactions, which manifested as rashes in 97.82%. Most of them had symptoms after seventh day following ERIG administration. Symptomatic relief with oral antihistamines like Cetirizine, Levocetirizine in 60% of cases and Inj. Avil (chlorpheniramine maleate) in 17% was achieved, and only one case required shortcourse corticosteroids. Conclusion: Despite 3.1% of serum sickness cases reported in our present study, the safety of ERIG has been proved and serum sickness can be managed with oral analgesics and antihistamines. Hence ERIG should be encouraged among doctors for use in category-III animal bite patients to prevent rabies.
Authors and Affiliations
Dr. Tapas Ranjan Behera
Keywords
Related Articles
- EP ID EP294959
- DOI 10.24321/0019.5138.201811
- Views 113
- Downloads 0
Prevalence of Multi-Drug Resistant Tuberculosis among Patients with HIV and Tuberculosis: The Indian Scenario
Introduction: Globally, India has the highest burden of tuberculosis (TB). In 2014, 2.2% of notified new cases and 15% of notified previously treated cases of pulmonary TB had multidrug resistant TB (MDR-TB). In addition...
Monitoring Household Filarial Infection Status under the Environment of Annual Mass Drug Administration (MDA) in a Village of Ghatampur, Kanpur, Uttarpradesh, India
The households infected with filariasis were given MDA in a village and monitored annually for change of mf infection. At end of 6 years 53% decline was observed in mf rate and 74% in mf mean counts. New infection was se...
Evaluation of Fast-food and Prepared Food Contamination with Health Pests
Background: Biologic and pathogenic contamination of food is the most important cause of illness and death in developing countries. Providing food security during the food preparation for restaurants and selfservices is...
Prevalence of Ixodid Ticks in Some States of the Country and its Public Health Importance
Ticks are the obligate haematophagus ectoparasites of animals and also associated with human affliction since time immemorial. They are playing the role as reservoirs and vectors of many zoonotic pathogens, responsible f...
The Pro-inflammatory Markers and Cytokine Profile in Acute Chikungunya Virus Infections in a Rural Community from North India
Analysis of pro-inflammatory markers, i.e., nitrite, citrulline, tumor necrosis alfa (TNF-α ) and Th1 and Th2-specific cytokines, viz., IL-2 and IL-4 respectively were analyzed in 30 sera positive for IgM antibodies to C...